Journal of Pharmaceutical Analysis · 2013 · 11 citations · 6 references
PharmacyChemistryPharmacologyAnalytical ChemistryMass Spectrometric AnalysisSpectroscopyChromatographyImpurity IsolationLiquid ChromatographySpectroscopic Analysis Of PharmaceuticalsStructural ElucidationStructural Elucidation Of ImpuritiesActive Pharmaceutical Ingredient IdentificationDrug Impurity AnalysisElectrospray IonizationHigh-performance Liquid ChromatographyLiquid Chromatography-mass SpectrometryNuclear Magnetic Resonance SpectroscopyUnknown Impurity CharacterizationUnknown Impurity Elucidation
A new impurity was detected during high performance liquid chromatographic (HPLC) analysis of eslicarbazepine acetate active pharmaceutical ingredient. The structure of unknown impurity was postulated based on liquid chromatography mass spectrometry using electrospray ionization and ion trap analyzer (LC/ESI–IT/MS) analysis. Proposed structure of impurity was unambiguously confirmed by synthesis followed by characterization using 1H, 13C nuclear magnetic resonance spectrometry (NMR), 1H–1H correlation spectroscopy (COSY) and infrared spectroscopy (IR). Based on the spectroscopic and spectrometric data, unknown impurity was characterized as 5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl propionate.
6
Ana Fortuna, Joana Sousa, Gilberto Alves et al. · Analytical and Bioanalytical Chemistry · 2010 · 70 citations
Gilberto Alves, Isabel Vitória Figueiredo, Margarida Castel‐Branco et al. · Biomedical Chromatography · 2007 · 33 citations · Full text
Saji Thomas, Amber Bharti, Pawan Kumar Maddhesia et al. · Journal of Pharmaceutical and Biomedical Analysis · 2011 · 19 citations
Mahesh Kumar Mone, K. B. Chandrasekhar · Journal of Pharmaceutical and Biomedical Analysis · 2010 · 15 citations